Home AbVitro

AbVitro

acquired
-
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

AbVitro is dedicated to advancing the treatment of poorly understood human diseases through potential immune components. Their mission is to harness the power of the human immune system and its role in complex diseases to discover new potential therapeutic targets or biomarkers, while also discovering and evaluating the therapeutic potential of respective fully human antibody conjugates. In short, they identify new therapeutic targets with matched therapeutic antibodies and/or T-cell receptors (TCR) in diseases with unmet medical needs.
AbVitro
Massachusetts,United States of America
101~500 people
January 01, 2010
bd@abvitro.com

Enterprise Profile

Industrial Sector
New Drug Development Scientific Research and Experimental Development Services
Application Scenarios
Innovative Drugs